.JPG?ad=18503&adview=true)
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Research Laboratories [K. C. A., D. W. L., D. R. H., J. E. M., S. P. C. C., R. G. D.] and Department of Pathology [K. C. A., D. R. H., S. P. C. C., R. G. D.], Queen's University, Kingston, Ontario, Canada K7L 3N6
Overexpression of multidrug resistance-associated protein (MRP) has been detected in resistant cell lines derived from a variety of tumor types. The deduced amino acid sequence of MRP suggests that it is a member of the ATP-binding cassette transmembrane transporter superfamily that may be glycosylated and/or phosphorylated [S. P. C. Cole et al., Science (Washington, DC), 258: 1650–1654, 1992]. Recently, transfection of HeLa cells with MRP expression vectors has demonstrated that the protein is capable of increasing resistance to natural product drugs such as anthracyclines, Vinca alkaloids, and epipodophyllotoxins (C. E. Grant et al., Cancer Res., 54: 357–361, 1994). Although the resistance phenotype of the transfectants is similar to that of the human small cell lung cancer cell line, H69AR, from which MRP was originally cloned, the transfectants differ in their drug accumulation characteristics, relative resistance to certain drugs, and MRP mRNA:protein ratio. Such differences have also been observed among drug-selected cell lines that overexpress MRP, and the underlying causes of these variable phenotypes are presently not known. We have utilized polyclonal anti-MRP-peptide antibodies to compare MRP post-translational modification, stability, processing, and subcellular distribution in the HeLa transfectants and in the drug-selected H69AR cells. These studies establish that MRP in both the transfected and selected cells is an ATP-binding, integral membrane glycophosphoprotein with an apparent molecular weight of 190,000. No obvious differences were detected in the extent or type of glycosylation or the kinetics of processing and turnover of the protein that might contribute to the different characteristics of the transfected and drug-selected cells. Analyses of the subcellular distribution of MRP by isopyknic density gradient centrifugation revealed that approximately 80% of MRP in the HeLa transfectants was associated with a low density plasma membrane fraction while the comparable fraction in the drug-selected H69AR cells contained only approximately 50% of the protein. The remaining MRP and plasma membrane markers were codistributed in higher density fractions consistent with the presence of MRP in endocytotic vesicles. The relatively high proportion of MRP associated with these fractions in H69AR cells may contribute to the lack of an observable accumulation defect in these cells when compared with the transfectants.
1 Supported by grants from the Medical Research Council of Canada and the Cancer Research Society, Inc. (S. P. C. C., R. G. D.). K. C. A. was supported by the Ontario Cancer Foundation and Queen's University, D. R. H. and J. E. M. are the recipients of a studentship and postdoctoral fellowship, respectively, from the Medical Research Council. S. P. C. C. is a Career Scientist of the Ontario Cancer Foundation and R. G. D. is the Stauffer Research Professor of Queen's University.
2 To whom requests for reprints should be addressed, at Cancer Research Laboratoires, Queen's University, Kingston, Ontario, Canada K7L 3N6.
Received 8/10/94. Accepted 10/31/94.
This article has been cited by other articles:
|
|
 |
|
  C. L. Hammond, R. Marchan, S. M. Krance, and N. Ballatori Glutathione Export during Apoptosis Requires Functional Multidrug Resistance-associated Proteins J. Biol. Chem., May 11, 2007; 282(19): 14337 - 14347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Deeley, C. Westlake, and S. P. C. Cole Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins. Physiol Rev, July 1, 2006; 86(3): 849 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kwok, A. Yamauchi, R. Rajesan, L. Chan, U. Dhillon, W. Gao, H. Xu, B. Wang, S. Takahashi, J. Semple, et al. Carnitine/xenobiotics transporters in the human mammary gland epithelia, MCF12A Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R793 - R802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Zhang, X. Tian, P. Chandra, and K. L. R. Brouwer Role of Glycosylation in Trafficking of Mrp2 in Sandwich-Cultured Rat Hepatocytes Mol. Pharmacol., April 1, 2005; 67(4): 1334 - 1341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Walle and U. K. Walle THE {beta}-D-GLUCOSIDE AND SODIUM-DEPENDENT GLUCOSE TRANSPORTER 1 (SGLT1)-INHIBITOR PHLORIDZIN IS TRANSPORTED BY BOTH SGLT1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS 1/2 Drug Metab. Dispos., November 1, 2003; 31(11): 1288 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Vaidyanathan and T. Walle Cellular Uptake and Efflux of the Tea Flavonoid (-)Epicatechin-3-gallate in the Human Intestinal Cell Line Caco-2 J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 745 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gao, H.-R. Cui, D. W. Loe, C. E. Grant, K. C. Almquist, S. P. C. Cole, and R. G. Deeley Comparison of the Functional Characteristics of the Nucleotide Binding Domains of Multidrug Resistance Protein 1 J. Biol. Chem., April 21, 2000; 275(17): 13098 - 13108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Litman, M Brangi, E Hudson, P Fetsch, A Abati, D. Ross, K Miyake, J. Resau, and S. Bates The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2) J. Cell Sci., January 6, 2000; 113(11): 2011 - 2021. [Abstract] [PDF]
|
|
|
|
|
|
B. D. Stride, S. P. C. Cole, and R. G. Deeley Localization of a Substrate Specificity Domain in the Multidrug Resistance Protein J. Biol. Chem., August 6, 1999; 274(32): 22877 - 22883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Gutmann, M. Török, G. Fricker, J. Huwyler, C. Beglinger, and J. Drewe Modulation of Multidrug Resistance Protein Expression in Porcine Brain Capillary Endothelial Cells In Vitro Drug Metab. Dispos., August 1, 1999; 27(8): 937 - 941. [Abstract] [Full Text]
|
|
|
|
|
|
A. H. Dantzig, R. L. Shepard, K. L. Law, L. Tabas, S. Pratt, J. S. Gillespie, S. N. Binkley, M. T. Kuhfeld, J. J. Starling, and S. A. Wrighton Selectivity of the Multidrug Resistance Modulator, LY335979, for P-Glycoprotein and Effect on Cytochrome P-450 Activities J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 854 - 862. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Hoffmann, P. Schmidt-Peter, W. Hansch, H. Naundorf, A. Bunge, M. Becker, and I. Fichtner Anticancer Drug Sensitivity and Expression of Multidrug Resistance Markers in Early Passage Human Sarcomas Clin. Cancer Res., August 1, 1999; 5(8): 2198 - 2204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-C. Peng, F. Cluzeaud, M. Bens, J.-P. D. Van Huyen, M. A. Wioland, R. Lacave, and A. Vandewalle Tissue and Cell Distribution of the Multidrug Resistance-Associated Protein (MRP) in Mouse Intestine and Kidney J. Histochem. Cytochem., June 1, 1999; 47(6): 757 - 768. [Abstract] [Full Text]
|
|
|
|
|
|
D. R. Hipfner, Q. Mao, W. Qiu, E. M. Leslie, M. Gao, R. G. Deeley, and S. P. C. Cole Monoclonal Antibodies That Inhibit the Transport Function of the 190-kDa Multidrug Resistance Protein, MRP. LOCALIZATION OF THEIR EPITOPES TO THE NUCLEOTIDE-BINDING DOMAINS OF THE PROTEIN J. Biol. Chem., May 28, 1999; 274(22): 15420 - 15426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Roelofsen, G. Hooiveld, H Koning, R Havinga, P. Jansen, and M Muller Glutathione S-conjugate transport in hepatocytes entering the cell cycle is preserved by a switch in expression from the apical MRP2 to the basolateral MRP1 transporting protein J. Cell Sci., January 5, 1999; 112(9): 1395 - 1404. [Abstract] [PDF]
|
|
|
|
|
|
M. Gao, M. Yamazaki, D. W. Loe, C. J. Westlake, C. E. Grant, S. P. C. Cole, and R. G. Deeley Multidrug Resistance Protein. IDENTIFICATION OF REGIONS REQUIRED FOR ACTIVE TRANSPORT OF LEUKOTRIENE C4 J. Biol. Chem., April 24, 1998; 273(17): 10733 - 10740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-B. Chang, Y.-X. Hou, and J. R. Riordan ATPase Activity of Purified Multidrug Resistance-associated Protein J. Biol. Chem., December 5, 1997; 272(49): 30962 - 30968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kast and P. Gros Topology Mapping of the Amino-terminal Half of Multidrug Resistance-associated Protein by Epitope Insertion and Immunofluorescence J. Biol. Chem., October 17, 1997; 272(42): 26479 - 26487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Hipfner, K. C. Almquist, E. M. Leslie, J. H. Gerlach, C. E. Grant, R. G. Deeley, and S. P. C. Cole Membrane Topology of the Multidrug Resistance Protein (MRP). A STUDY OF GLYCOSYLATION-SITE MUTANTS REVEALS AN EXTRACYTOSOLIC NH2 TERMINUS J. Biol. Chem., September 19, 1997; 272(38): 23623 - 23630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Stride, C. E. Grant, D. W. Loe, D. R. Hipfner, S. P. C. Cole, and R. G. Deeley Pharmacological Characterization of the Murine and Human Orthologs of Multidrug-Resistance Protein in Transfected Human Embryonic Kidney Cells Mol. Pharmacol., September 1, 1997; 52(3): 344 - 353. [Abstract] [Full Text]
|
|
|
|
 |
|
 Z. Zhan, V. A. Sandor, E. Gamelin, J. Regis, B. Dickstein, W. Wilson, A. T. Fojo, and S. E. Bates Expression of the Multidrug Resistance-Associated Protein Gene in Refractory Lymphoma: Quantitation by a Validated Polymerase Chain Reaction Assay Blood, May 15, 1997; 89(10): 3795 - 3800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gao, D. W. Loe, C. E. Grant, S. P.C. Cole, and R. G. Deeley Reconstitution of ATP-dependent Leukotriene C4 Transport by Co-expression of Both Half-molecules of Human Multidrug Resistance Protein in Insect Cells J. Biol. Chem., November 1, 1996; 271(44): 27782 - 27787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Loe, K. C. Almquist, R. G. Deeley, and S. P. C. Cole Multidrug Resistance Protein (MRP)-mediated Transport of Leukotriene C(4) and Chemotherapeutic Agents in Membrane Vesicles J. Biol. Chem., April 19, 1996; 271(16): 9675 - 9682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Loe, K. C. Almquist, S. P. C. Cole, and R. G. Deeley ATP-dependent 17beta-Estradiol 17-(beta-D-Glucuronide) Transport by Multidrug Resistance Protein (MRP) J. Biol. Chem., April 19, 1996; 271(16): 9683 - 9689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ruetz, M. Brault, C. Kast, C. Hemenway, J. Heitman, C. E. Grant, S. P. C. Cole, R. G. Deeley, and P. Gros Functional Expression of the Multidrug Resistance-associated Protein in the Yeast Saccharomyces cerevisiae J. Biol. Chem., February 23, 1996; 271(8): 4154 - 4160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Paumi, B. G. Ledford, P. K. Smitherman, A. J. Townsend, and C. S. Morrow Role of Multidrug Resistance Protein 1 (MRP1) and Glutathione S-Transferase A1-1 in Alkylating Agent Resistance. KINETICS OF GLUTATHIONE CONJUGATE FORMATION AND EFFLUX GOVERN DIFFERENTIAL CELLULAR SENSITIVITY TO CHLORAMBUCIL VERSUS MELPHALAN TOXICITY J. Biol. Chem., March 9, 2001; 276(11): 7952 - 7956. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
